Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Bloomberg Customers


February 11, 2016 12:54 AM ET

Healthcare Equipment and Supplies

Company Overview of Insulet Corporation

Executive Profile

Daniel J. Levangie B.S.

President of Insulet Drug Delivery, Insulet Corporation
AgeTotal Calculated CompensationThis person is connected to 5 Board Members in 5 different organizations across 11 different industries.

See Board Relationships
64$302,182

Background

Mr. Daniel J. Levangie, also known as Dan, has been President of Insulet Drug Delivery at Insulet Corporation since February 10, 2015. Mr. Levangie was a Managing Partner and Principal at Constitution Medical Investors. He has over three decades of industry experience including leadership expertise in the commercial operations and sales and marketing of medical devices and pharmaceuticals. Mr. Levangie served as a Managing Partner of ATON Partners, LLC, Investment Arm ...

Corporate Headquarters

600 Technology Park Drive
Billerica, Massachusetts 01821

United States

Phone: 978-600-7000
Fax: 978-600-0120

Board Members Memberships

Chairman
Chairman
2007-Present
Non-Executive Chairman and Member of Nominating, Corporate Governance & Compliance Committee
2010-Present
Independent Director, Chairman of Innovation & Technology Committee and Member of Corporate Governance & Nominating Committee
2010-Present
Director, Chairman of Nominating & Corporate Governance Committee and Member of Audit Committee

Education

BS
Northeastern University

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

Total Annual Cash Compensation$79,583
Total Calculated Compensation$302,182
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Kevin R. Sayer Chief Executive Officer, President and Director
DexCom, Inc.
$325.0K
Eric M. Green Chief Executive Officer, President and Director
West Pharmaceutical Services, Inc.
--
Andrew Reynolds Smith Chief Executive Officer and Executive Director
Smiths Group plc
--
Simon Michel Chief Executive Officer
Ypsomed Holding AG
$516.9K
Kim D. Blickenstaff Chief Executive Officer, President and Director
Tandem Diabetes Care, Inc.
$532.7K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Insulet Corporation, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.